A detailed history of Global Financial Private Client, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Global Financial Private Client, LLC holds 2,590 shares of BMY stock, worth $150,220. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,590
Previous 1,558 66.24%
Holding current value
$150,220
Previous $64.7 Million 107.11%
% of portfolio
0.05%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$39.66 - $51.75 $40,929 - $53,406
1,032 Added 66.24%
2,590 $134 Million
Q2 2024

Jul 29, 2024

SELL
$40.25 - $52.99 $36,225 - $47,691
-900 Reduced 36.62%
1,558 $64.7 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $2,303 - $2,611
-48 Reduced 1.92%
2,458 $130 Million
Q3 2023

May 15, 2024

SELL
$57.89 - $64.73 $3,589 - $4,013
-62 Reduced 2.41%
2,506 $145 Million
Q2 2023

May 15, 2024

SELL
$63.71 - $70.74 $19,176 - $21,292
-301 Reduced 10.49%
2,568 $165 Million
Q1 2023

May 15, 2024

SELL
$65.71 - $74.53 $2,102 - $2,384
-32 Reduced 1.1%
2,869 $200 Million
Q4 2022

May 15, 2024

BUY
$68.48 - $81.09 $26,570 - $31,462
388 Added 15.44%
2,901 $209 Million
Q3 2022

May 15, 2024

SELL
$0.13 - $76.84 $14 - $8,298
-108 Reduced 4.12%
2,513 $177 Million
Q2 2022

May 15, 2024

BUY
$72.62 - $79.98 $11,473 - $12,636
158 Added 6.41%
2,621 $201 Million
Q1 2022

May 15, 2024

SELL
$61.48 - $73.72 $11,619 - $13,933
-189 Reduced 7.13%
2,463 $182 Million
Q4 2021

May 15, 2024

SELL
$53.63 - $62.52 $434,456 - $506,474
-8,101 Reduced 75.34%
2,652 $165 Million
Q3 2021

May 15, 2024

BUY
$59.17 - $69.31 $30,472 - $35,694
515 Added 5.03%
10,753 $640 Million
Q2 2021

May 15, 2024

BUY
$61.91 - $67.42 $227,581 - $247,835
3,676 Added 56.02%
10,238 $681 Million
Q1 2021

May 15, 2024

BUY
$59.34 - $66.74 $32,458 - $36,506
547 Added 9.09%
6,562 $413 Million
Q4 2020

May 15, 2024

SELL
$57.74 - $65.43 $24,712 - $28,004
-428 Reduced 6.64%
6,015 $373 Million
Q3 2020

May 15, 2024

BUY
$57.43 - $63.64 $27,796 - $30,801
484 Added 8.12%
6,443 $385 Million
Q2 2020

May 15, 2024

BUY
$54.82 - $64.09 $27,410 - $32,045
500 Added 9.16%
5,959 $354 Million
Q1 2020

May 15, 2024

BUY
$46.4 - $67.43 $180,264 - $261,965
3,885 Added 246.82%
5,459 $299 Million
Q4 2019

May 15, 2024

BUY
$49.21 - $64.19 $77,456 - $101,035
1,574 New
1,574 $101 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Global Financial Private Client, LLC Portfolio

Follow Global Financial Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.